NAPROXEN AND ESOMEPRAZOLE MAGNESIUM Drug Patent Profile
✉ Email this page to a colleague
When do Naproxen And Esomeprazole Magnesium patents expire, and what generic alternatives are available?
Naproxen And Esomeprazole Magnesium is a drug marketed by Actavis Labs Fl Inc, Ajanta Pharma Ltd, Dr Reddys, Mylan, and Sciegen Pharms Inc. and is included in five NDAs.
The generic ingredient in NAPROXEN AND ESOMEPRAZOLE MAGNESIUM is esomeprazole magnesium; naproxen. There are seventy-four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the esomeprazole magnesium; naproxen profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAPROXEN AND ESOMEPRAZOLE MAGNESIUM?
- What are the global sales for NAPROXEN AND ESOMEPRAZOLE MAGNESIUM?
- What is Average Wholesale Price for NAPROXEN AND ESOMEPRAZOLE MAGNESIUM?
Summary for NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 3 |
| What excipients (inactive ingredients) are in NAPROXEN AND ESOMEPRAZOLE MAGNESIUM? | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM excipients list |
| DailyMed Link: | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM at DailyMed |
US Patents and Regulatory Information for NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium; naproxen | TABLET, DELAYED RELEASE;ORAL | 204470-001 | Aug 24, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium; naproxen | TABLET, DELAYED RELEASE;ORAL | 204920-001 | Jul 20, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ajanta Pharma Ltd | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium; naproxen | TABLET, DELAYED RELEASE;ORAL | 213699-002 | Oct 6, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium; naproxen | TABLET, DELAYED RELEASE;ORAL | 204920-002 | Jul 20, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Actavis Labs Fl Inc | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium; naproxen | TABLET, DELAYED RELEASE;ORAL | 204470-002 | Aug 24, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
